Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/41231514/
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study
Upadacitinib demonstrated sustained efficacy across musculoskeletal and skin domains in PsA patients with prior inadequate response to TNF inhibitors, with a...
psoriatic arthritistnf inhibitorupadacitinibpriorfailure